Leader in clinical trial payment solutions sees nearly 200 percent revenue growth, driven by industry focus on optimization, collaboration and superior clinical trial experiences
King of Prussia, PA — November 17, 2016 — Greenphire, the global leader in clinical payment solutions, announced today that it has been named to Deloitte’s 2016 Technology Fast 500, which recognizes the fastest-growing technology, media, telecommunications, life sciences, and energy technology companies in North America. Greenphire grew 190 percent during this period, putting the company at number 369 on the list.
“We are honored to be recognized by Deloitte among the most elite, fastest-growing companies in North America,” said Jim Murphy, CEO of Greenphire. “Our growth is a result of the clinical trial industry’s focus on both site and patient centricity. With two unique solutions designed to eliminate manual processes, streamline operations and improve the clinical trial experience for all involved, we poised to continue this tremendous growth for years to come.”
Greenphire provides best-in-class payment solutions designed to optimize clinical trial research site operations. Its two solutions, eClinicalGPS and ClinCard, enable better payments to sites and clinical trial participants, resulting in a more efficient, streamlined trial operations.
“Today, when every organization can be a tech company, the most effective businesses not only foster the courage to explore change, but also encourage creativity in using and applying existing assets in new ways, as resourcefully as possible,” said Sandra Shirai, principal, Deloitte Consulting LLP and U.S. technology, media and telecommunications industry leader. “This ingenious approach to innovation calls for the encouragement of curiosity and collaboration both within and outside the office walls.”
“This year’s Fast 500 winners showcase that when organizations are open to diverse perspectives and insights, they are able to create an environment for their employees and customers to see the possibilities and ingenious solutions that might lie ahead,” added Jim Atwell, national managing partner of the emerging growth company practice, Deloitte & Touche LLP. “Entrepreneurial environments foster change and innovation within businesses, and we look forward to watching these companies continue to drive change across all sectors.”
Overall, 2016 Technology Fast 500™ companies achieved revenue growth ranging from 121 percent to 66,661 percent from 2012 to 2015, with median growth of 290 percent.
About Deloitte’s 2016 Technology Fast 500™
Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2012 to 2015. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America. As used in this document, “Deloitte” means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
About Greenphire
Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.
